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Background
Cigarette smoking is a well-described risk factor for a
number of cancers and has been implicated as the most
significant cause of urothelial cancer, conferring up to a
7-fold increased risk. Urothelial cancers are also part of
the spectrum of cancers associated with Lynch syn-
drome. Several studies have looked at the impact of
gene-environment interaction on cancer risk in Lynch
syndrome and have found that smoking may increase
the risk for colorectal cancer. However, the interaction
of smoking and mismatch repair (MMR) genotype has
never been evaluated for urothelial cancer risk.
Methods
Three existing cancer registry data sets are being uti-
lized for this analysis including Colon-Cancer Family
Registries, Dana-Farber Cancer Institute, and City of
Hope. These data sets contain information about indivi-
duals with confirmed MMR gene mutations, age, race,
gender, cancer diagnoses, and smoking status. Subjects
were recruited using different strategies, with some
being identified through population based recruitment
and others being identified through high-risk clinics.
Urothelial cancers included transitional cell cancers of
the collecting system and bladder. Individual subject
data will be assigned weights associated with inverse
probability of being included in the sample based on
recruiting methods and stratified to account for popula-
tion versus clinic recruitment. A standardized incidence
ratio (SIR) will be calculated by comparing the observed
versus expected number of urothelial cancers among
smokers and nonsmokers with MMR repair mutations.
SEER data will be used to determine the expected
number of cancers. Poison regression techniques will be
used to determine if smoking has a significant effect on
the SIRs.
Results
From these three datasets, 1185 MMR mutation carriers
were identified, and smoking data was available for 1107
(93.4%). Subjects were dichotomized as ever smokers if
they had ever smoked a cigarette a day for three or
more months or never smokers. Based on this definition
580 (52.4%) were never smokers, and 527 (47.6%) were
smokers. There were a total of34 urothelial cancers
diagnosed in the entire study population, corresponding
t oap r e v a l e n c eo f3 . 1% .T h em e a na g ea td i a g n o s i so f
urothelial cancer was 55.5 years (range 34-79 years).
Urothelial cancer was the first cancer diagnosis in 10
cases (29.4%). Thirteen (38.2%) had one prior cancer,
and 11(32.4%) had two or more prior cancers. Smoking
d a t aw e r ea v a i l a b l eo n2 6c a s e s .O ft h o s e ,1 6( 6 1 . 5 % )
occurred in nonsmokers, and 10 (38.5%) occurred in
smokers.
Conclusion
Our data suggest that the prevalence of urothelial cancer
in MMR mutation carriers is approximately 3%. Risk esti-
mates will be adjusted for age and gender and appropri-
ately weighted and stratified to account for subject
ascertainment, in order to complete our calculation of
the SIR. Determining the role of gene-environment inter-
actions will be important for understanding differences in
cancer risk among Lynch syndrome families and for tar-
geting modifiable lifestyle factors for risk reduction.
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